Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease

Details for Australian Patent Application No. 2011215963 (hide)

Owner Lexicon Pharmaceuticals, Inc.

Inventors Sands, Arthur Thomas

Agent Pizzeys

Pub. Number AU-A-2011215963

PCT Pub. Number WO2011/100285

Priority 61/303,002 10.02.10 US

Filing date 9 February 2011

Wipo publication date 18 August 2011

International Classifications

A61K 31/4045

A61K 31/4192 - 1,2,3-Triazoles

A61K 31/497

A61K 31/506 - not condensed and containing further heterocyclic rings

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 35/04 Antineoplastic agents

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/100285 Priority application(s): WO2011/100285

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011215966-Phosphate bonded composites and methods

2011215956-Methods and systems for health wellness management